Understanding how sperm survive in the oviduct despite immune responses
Oviduct Siglecs: Role in the Sperm Immune Response
This study is looking at how sperm can safely hang out in the oviduct without being attacked by the immune system, which is important for helping them reach the egg for fertilization.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10997422 on NIH RePORTER |
What this research studies
This research investigates the unique ability of sperm to survive in the oviduct, where they are not attacked by the immune system, unlike in the uterus. The study focuses on the interactions between sperm and uterine cells, particularly how sperm can evade phagocytosis by immune cells. By examining the role of specific molecules called Siglecs and the sialic acid-terminating glycans on sperm, the research aims to uncover the mechanisms that allow sperm to persist in the oviduct for extended periods, which is crucial for successful fertilization.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing infertility or difficulties in conception.
Not a fit: Patients who are not trying to conceive or have no fertility issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into fertility and potential treatments for individuals facing challenges in achieving pregnancy.
How similar studies have performed: While the specific mechanisms of sperm survival in the oviduct are not fully understood, similar research has shown promise in understanding immune interactions in reproductive biology.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Miller, David Joel — University of Illinois at Urbana-Champaign
- Study coordinator: Miller, David Joel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.